Skip to main content

Research Repository

Advanced Search

Continuous femoral nerve block as pain management following total knee arthroplasty: a systematic review.

Migliorini, Filippo; Pappalardo, Gaetano; Bardazzi, Tommaso; Maffulli, Nicola; Bertini, Francesca Alzira; Simeone, Francesco; Vaishya, Raju; Memminger, Michael Kurt

Authors

Filippo Migliorini

Gaetano Pappalardo

Tommaso Bardazzi

Nicola Maffulli

Francesca Alzira Bertini

Francesco Simeone

Raju Vaishya

Michael Kurt Memminger



Abstract

The present systematic review evaluated the current level of I evidence on continuous femoral nerve block (FNB) as pain management following total knee arthroplasty (TKA), comparing different drugs. This study followed the 2020 PRISMA guidelines. PubMed, Embase and Web of Science were accessed in November 2024. All clinical studies concerning continuous FNB for pain management following TKA were considered. Data from 22 RCTs were retrieved. The drugs included in the analyses were levobupivacaine, bupivacaine and ropivacaine in isolation or combined with prilocaine or dexmedetomidine. A statistically significant difference was found in VAS at rest in postoperative day (POD) 0 (p < 0.01): the bupivacaine group demonstrated the highest values, and the ropivacaine combined with dexmedetomidine group had the lowest values. No other statistically significant difference in VAS at rest was found for any group in POD 1, 2, and 3 (p = 0.1, p = 0.1, and p = 0.4, respectively). The groups receiving ropivacaine combined with dexmedetomidine and prilocaine had the lowest values of VAS during activity in POD2 (p < 0.01), while in POD3 the groups receiving ropivacaine combined with prilocaine and the bupivacaine one had the lowest values (p < 0.01). No significant difference was found in VAS during activity between any group in POD 0 (p = 0.4) and POD 1 (p = 0.3). Ropivacaine combined with dexmedetomidine might be the best compound for continuous femoral nerve block to manage pain following TKA during the first PODs. Further high-quality investigations are necessary to validate these findings in clinical settings. [Abstract copyright: © 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.]

Citation

Migliorini, F., Pappalardo, G., Bardazzi, T., Maffulli, N., Bertini, F. A., Simeone, F., Vaishya, R., & Memminger, M. K. (2025). Continuous femoral nerve block as pain management following total knee arthroplasty: a systematic review. Archives of Orthopaedic and Trauma Surgery, 145(1), Article 238. https://doi.org/10.1007/s00402-025-05855-3

Journal Article Type Article
Acceptance Date Mar 28, 2025
Online Publication Date Apr 11, 2025
Publication Date Apr 11, 2025
Deposit Date Apr 29, 2025
Journal Archives of orthopaedic and trauma surgery
Print ISSN 0936-8051
Electronic ISSN 1434-3916
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 145
Issue 1
Article Number 238
DOI https://doi.org/10.1007/s00402-025-05855-3
Keywords Management, Nerve Block - methods, Pain, Postoperative - therapy - prevention & control, Ropivacaine - administration & dosage, Dexmedetomidine - administration & dosage, Arthroplasty, Replacement, Knee - adverse effects, Femoral Nerve, Femoral nerve block, Arthroplasty, Anesthetics, Local - administration & dosage, Knee, Humans, Pain, Pain Management - methods, Bupivacaine - administration & dosage
Public URL https://keele-repository.worktribe.com/output/1200213
Publisher URL https://link.springer.com/article/10.1007/s00402-025-05855-3